coronavirus vaccines ready for production by the end of the year, a professor overseeing the trial claims. Chief investigator of the Oxford/AstraZeneca vaccine trial Professor Andrew Pollard says he is “optimistic” about getting approval on the jab by Christmas.He has said his team's “miracle” work has been done at “record speed”, adding that the vaccine is on the cusp of demonstrating “efficacy”.
It comes after pharmaceutical company Pfizer announced its vaccine candidate is more than 90% effective in preventing Covid-19.And now Professor Pollard has said the Oxford vaccine will be 10 times cheaper than the Pfizer/BioNTech jab and easier to deliver because it doesn't have to be stored at temperatures below -70C.